Dr. Ben Williams is a Program Officer for the Helmsley Charitable Trust’s Type 1 Diabetes Program (T1D). He helps to oversee a biomedical research grant portfolio that identifies and invests in promising therapies for T1D.

Prior to joining Helmsley, Ben was a senior science writer at Fred Hutchinson Cancer Research Center where he helped steward the scientific aspects of the institute’s philanthropic partnerships. Previously, he was a postdoctoral fellow in Nobel Laureate Dr. Linda Buck’s laboratory, studying in the field of neuroscience. He has also held research internships at Brigham and Women’s Hospital and Eli Lilly & Co.

Ben earned a Ph.D. in genetics from Harvard Medical School’s biological and biomedical sciences program and earned a Bachelor of Arts degree in chemistry from Earlham College.